Taat Global Alternatives Reports Q3 Earnings Growth

Sep.23.2022
Taat Global Alternatives Reports Q3 Earnings Growth
Taat Global Alternatives reports Q3 revenue of CAD 17.47 million and asset growth of 48.77% to USD 23.38 million.

According to a report from Taat Global Alternatives, for the three-month period ending on July 31, 2022, the company generated revenue of CAD $17.47 million (equivalent to USD $12.93 million) and gross profit of USD $567,404. Assets increased 48.77% compared to the same quarter of the previous year, reaching USD $23.38 million.


I am very pleased with our performance in the third quarter of 2022 as it reflects the many achievements we have made in strengthening our financial position as a comprehensive innovator, manufacturer and distributor of tobacco alternative and other emerging product categories," said Michael Saxon, CEO of Taat in a statement.


We are continuing to strategically commercialize Taat as a category creator, which is now being sold in thousands of stores across the United States and United Kingdom, including prominent convenience and chain store display locations.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth and accuracy of the content. The translation of this article is only intended for industry communication and research.


Due to limitations in the level of translation ability, the translated article may not fully express the meanings of the original text. Please refer to the original text for accuracy.


2FIRSTS fully aligns with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related issues and positions.


Copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Court Backs FDA Ban on Bidi Vapor’s Tobacco-Flavored E-Cigarettes
U.S. Court Backs FDA Ban on Bidi Vapor’s Tobacco-Flavored E-Cigarettes
The U.S. Court of Appeals for the Eleventh Circuit upheld the FDA’s decision to deny marketing authorization for Bidi Vapor LLC’s tobacco-flavored e-cigarette product, Bidi Stick - Classic.
Apr.25 by 2FIRSTS.ai
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA staff cuts impact tobacco enforcement: HHS layoffs jeopardize fines on retailers, potentially hindering tobacco law enforcement.
Apr.17 by 2FIRSTS.ai
PMI speaks out: IQOS is not an e-cigarette, legal to sell in Mexico
PMI speaks out: IQOS is not an e-cigarette, legal to sell in Mexico
Philip Morris International (PMI) defends the legality of IQOS as a heated tobacco device in Mexico.
Apr.18 by 2FIRSTS.ai
Insufficient Heating: Pain Point of Susceptor-Embedded HNB Smoking Article and Solutions thereof
Insufficient Heating: Pain Point of Susceptor-Embedded HNB Smoking Article and Solutions thereof
This article, contributed by patent attorney Ren Yongli to 2Firsts, analyzes the structural pain points of PMI's Terea sticks in electromagnetic heating and reviews technical solutions proposed by various industry players, including BAT, Shenzhen-based companies, and PMI’s own improvement strategies.
May.30
Health Canada Issues Recall for "Crystal" E-cigarette Liquid Products
Health Canada Issues Recall for "Crystal" E-cigarette Liquid Products
Health Canada has issued a recall for 250ml bottles of "Crystal" e-cigarette liquid due to safety concerns, citing the potential health risks.
Apr.25 by 2FIRSTS.ai
BAT Cuts Stake in India’s ITC by $1.5 Billion
BAT Cuts Stake in India’s ITC by $1.5 Billion
British American Tobacco (BAT) sold $1.5 billion worth of shares in Indian consumer goods company ITC at a price of 413 Indian rupees per share.
May.28